Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · CHIEF EXECUTIVE OFFICER | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 806,111 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 5,361 · Balance 806,111 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1 |
Reported balance
Holding disclosure · report date 2026-09-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1 F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
F2: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 60 | $39.45 | $2,367.00 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 191,277 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 240 | $39.45 | $9,468.00 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 13, 2022 Filed Oct 17, 2022 20:46 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 240 | $3.95 | $948.00 |
DisclosureSEC source: 0001628280-22-026505 · wf-form4_166603949643612.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 19,602 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · derivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494,513 Underlying: Common Stock · 19,602 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,901 | $40.24 | $197,216.24 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 191,337 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 19,602 | $40.24 | $788,784.48 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.08 to $40.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 06, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 19,602 | $3.95 | $77,427.90 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 1,440 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · derivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514,115 Underlying: Common Stock · 1,440 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 360 | $40.18 | $14,464.80 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 196,238 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,440 | $40.18 | $57,859.20 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 F2 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,440 | $3.95 | $5,688.00 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 74,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 196,598 F1 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:35 UTC | Progyny, Inc. PGNY · Entity 4521 | GiftCommon Stock | 74,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-026162 · wf-form4_166517491402058.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,445 Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 3,812 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-024749 · wf-form4_166301564664638.xml · derivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515,555 Underlying: Common Stock · 3,812 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 221 | $43.30 | $9,569.30 |
DisclosureSEC source: 0001628280-22-024749 · wf-form4_166301564664638.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 122,127 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.225 to $43.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 732 | $43.02 | $31,490.64 |
DisclosureSEC source: 0001628280-22-024749 · wf-form4_166301564664638.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 122,348 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.24 to $43.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 882 | $43.30 | $38,190.60 |
DisclosureSEC source: 0001628280-22-024749 · wf-form4_166301564664638.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.225 to $43.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,930 | $43.02 | $126,048.60 |
DisclosureSEC source: 0001628280-22-024749 · wf-form4_166301564664638.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,798 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.24 to $43.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:47 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 3,812 | $3.95 | $15,057.40 |
DisclosureSEC source: 0001628280-22-024749 · wf-form4_166301564664638.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · derivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,519,367 Underlying: Common Stock · 32,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,145 | $42.04 | $132,215.80 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 10 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 123,080 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.76 to $42.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,115 | $41.54 | $170,937.10 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 9 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 126,225 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.75 to $41.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 740 | $40.22 | $29,762.80 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 130,340 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.73 to $40.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 12,583 | $42.04 | $528,989.32 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.76 to $42.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 16,457 | $41.54 | $683,623.78 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,499 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.75 to $41.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 2,960 | $40.22 | $119,051.20 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,956 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.73 to $40.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 32,000 | $3.95 | $126,400.00 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 28,029 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · derivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,551,367 Underlying: Common Stock · 28,029 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,006 | $39.45 | $276,386.70 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 131,080 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 28,029 | $39.45 | $1,105,744.05 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.44 to $39.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 07, 2022 Filed Sep 9, 2022 21:06 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 28,029 | $3.95 | $110,714.55 |
DisclosureSEC source: 0001628280-22-024698 · wf-form4_166275758334294.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 160 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · derivative · entry 8 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,579,396 Underlying: Common Stock · 160 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 40 | $39.25 | $1,570.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · nonDerivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 138,086 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.08 to $39.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 160 | $39.25 | $6,280.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.08 to $39.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 160 | $3.95 | $632.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionOption (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · derivative · entry 7 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,579,556 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,000 | $38.98 | $155,920.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 138,126 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 16,000 | $38.98 | $623,680.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:22 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-22-024367 · wf-form4_166249572423714.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-023022 · wf-form4_166068119278186.xml · derivative · entry 6 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,595,556 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 100 | $45.25 | $4,525.00 |
DisclosureSEC source: 0001628280-22-023022 · wf-form4_166068119278186.xml · nonDerivative · entry 5 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 142,126 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.25 to $45.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,900 | $44.90 | $175,110.00 |
DisclosureSEC source: 0001628280-22-023022 · wf-form4_166068119278186.xml · nonDerivative · entry 4 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 142,226 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.24 to $45.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 400 | $45.25 | $18,100.00 |
DisclosureSEC source: 0001628280-22-023022 · wf-form4_166068119278186.xml · nonDerivative · entry 3 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.25 to $45.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 15,600 | $44.90 | $700,440.00 |
DisclosureSEC source: 0001628280-22-023022 · wf-form4_166068119278186.xml · nonDerivative · entry 2 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,316 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.24 to $45.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:20 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 16,000 | $3.95 | $63,200.00 |
DisclosureSEC source: 0001628280-22-023022 · wf-form4_166068119278186.xml · nonDerivative · entry 1 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,916 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock · Derivative | 16,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001628280-22-022674 · wf-form4_166033521077614.xml · derivative · entry 16 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,611,556 Underlying: Common Stock · 16,000 shares Expires 2029-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 305 | $45.25 | $13,801.25 |
DisclosureSEC source: 0001628280-22-022674 · wf-form4_166033521077614.xml · nonDerivative · entry 14 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 146,126 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.14 to $45.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,695 | $44.63 | $164,907.85 |
DisclosureSEC source: 0001628280-22-022674 · wf-form4_166033521077614.xml · nonDerivative · entry 13 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 146,431 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.13 to $45.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,219 | $45.25 | $55,159.75 |
DisclosureSEC source: 0001628280-22-022674 · wf-form4_166033521077614.xml · nonDerivative · entry 12 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,916 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.14 to $45.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:13 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 14,781 | $44.63 | $659,676.03 |
DisclosureSEC source: 0001628280-22-022674 · wf-form4_166033521077614.xml · nonDerivative · entry 11 Anevski Peter · CIK 0001576147 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,135 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.13 to $45.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.